Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma

Clinical Cancer Research

Volumn 8, Issue 1, 2002, Pages 131-137

  Kwong, Joseph ^a   Lo, Kwok Wai ^a   To, Ka Fai ^a   Teo, Peter M L ^a   Johnson, Philip J ^a   Poon Huang, Dolly ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLUTATHIONE TRANSFERASE P1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P14; PROTEIN P15; PROTEIN P16; PROTEIN RAR BETA2; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; METHYLATION; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

APOPTOSIS REGULATORY PROTEINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA PRIMERS; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HELMINTH PROTEINS; HUMANS; ISOENZYMES; MUSCLE PROTEINS; MUTATION; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS (GENETICS); RECEPTORS, RETINOIC ACID; SURVIVAL RATE; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0036152306     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Aetiological factorspathogenesis
2. Nasopharyngeal carcinoma: An epidemiological approach to carcinogenesis
3. Alternations in DNA methylation: A fundamental aspect of neoplasia
4. Cancer epigenetics comes of age
5. Hypomethylation of DNA from benign and malignant human colon neoplasms
6. Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma
7. 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers
8. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
9. Incidence and functional consequences of hMLHI promoter hypermethylation in colorectal carcinoma
10. Cytidine methylation of regulatory sequences near the Eπ-class glutathione S-transferase gene accompanies human prostatic carcinogenesis
11. 6-methylguanine-DNA-methyltransferase by promoter hypermethylation is a common event in multiple human neoplasia
12. Hypermethylation of the DAP-kinase CpG island is a common alternation in B-cell malignancies
13. Hypermethylation of the p16 gene in nasopharyngeal carcinoma
14. High frequency of promoter hypermethylation of RASSFIA in nasopharyngeal carcinoma
15. INK4a, is an early event in lung cancer and a potential biomarker for early diagnosis
16. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of nasopharynx
17. Nasopharyngeal carcinoma cell line (C666-1) consistently harboring Epstein-Barr virus
18. Cytogenetics of undifferentiated carcinoma xenografts from southern Chinese
19. Detailed deletion mapping on the short arm of chromosome 3 in nasopharyngeal carcinoma
20. Histological typing of upper respiratory tract tumor
21. Stage classification of nasopharyngeal carcinoma: A review
22. Methylation-specific PCR. A novel PCR assay for methylation status of CpG islands
23. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells
24. INK4a methylation and p53 mutational status
25. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia
26. DNA hypermethylation in tumor-igenesis: Epigenetics joins genetics
27. A gene hypermethylation profile of human cancer
28. Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3
29. Substrate specificities and identification of putative substrates of ATM kinase family members
30. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers
31. Methylation associated inactivation of RASSFIA from region 3p21.3 in lung, breast, and ovarian tumors
32. Epigenetic inactivation of RASSF 1A in lung and breast cancers and malignant phenotype suppression
33. Hypermethylation of multiple genes in pancreatic adenocarcinoma
34. Methylation and silencing of the retinoic acid receptor-β2 gene in breast cancer
35. Biallelic inactivation of retinoic acid receptor β2 gene by epigenetic change in breast cancer
36. Promoter methylation and silencing of the retinoid acid receptor-β gene in lung carcinomas
37. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients
38. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
39. p16 gene alternations in nasopharyngeal carcinoma
40. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
41. 1NK4B is a potential effector of TGF-β-induced cell cycle
42. 6-alkylguanine-DNA alkyltransferase regulation and importance in response to alkylating carcinogenic and therapeutic agents
43. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis
44. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
45. Glutathione S-transferases. Gene structure and regulation of expression
46. Detection of aberrant promoter hypermethylation of tumor suppressor gene in serum DNA from non-small cell lung cancer patients
47. Predicting lung cancer by detecting aberrant promoter methylation in sputum
48. 6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients
49. Nasopharyngeal brush biopsies and detection of nasopharyngeal cancer in a high-risk population